EW News and Press, Edwards Lifesciences Corporation From 06/03/24

2024-06-03 15:19:23 ET More on the markets S&P 500 Investor Focus Shifts Forward To Q4 2024 Nasdaq, S&P, and Dow trade mixed while yields slide Tech Sector Revisions Still Positive After Salesforce Last Week Stock volatility may pick up in June after ...

Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to report that further to its news release of April 30 th , 2024 the purchaser has now obtained final approvals from New Zealand Petroleum & Minera...

2024-05-28 17:28:30 ET Summary Simplify Market Neutral Equity Long/Short ETF implements a leveraged long-short stock strategy based on machine learning. The EQLS ETF is net long in financials and energy, and net short in healthcare and consumer staples. Over the last 11 months...

2024-05-28 05:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-22 13:55:06 ET More on Establishment Labs, Edwards Lifesciences, etc. Establishment Labs Holdings Inc. (ESTA) Q1 2024 Earnings Call Transcript Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade) Nevro Corp. (NVRO) Q1 2024 Earnings ...

2024-05-18 06:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-13 11:11:20 ET More on Edwards Lifesciences Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade) Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Of...

2024-05-09 00:31:25 ET Summary Health Care sector performance in the S&P 500 has been mixed, with some companies struggling while Eli Lilly dominates amid a focus on GLP-1s. Edwards Lifesciences Corporation is a leader in the transcatheter heart valve replacement market and fe...

Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra...

2024-05-06 21:30:02 ET Barclays analyst issues OVERWEIGHT recommendation for EW on May 6, 2024 08:09PM ET. The previous analyst recommendation was Overweight. EW was trading at $85.09 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...